Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

OCIA domain-containing protein 1 (Ovarian cancer immunoreactive antigen domain containing 1) (Ovarian carcinoma immunoreactive antigen)

 OCAD1_HUMAN             Reviewed;         245 AA.
Q9NX40; C9K030; G8JLN7; Q9BZE8;
11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
01-OCT-2000, sequence version 1.
10-OCT-2018, entry version 141.
RecName: Full=OCIA domain-containing protein 1;
AltName: Full=Ovarian cancer immunoreactive antigen domain containing 1 {ECO:0000303|PubMed:20515946};
AltName: Full=Ovarian carcinoma immunoreactive antigen;
Name=OCIAD1 {ECO:0000312|HGNC:HGNC:16074};
Synonyms=ASRIJ {ECO:0000250|UniProtKB:Q9CRD0}, OCIA;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
TISSUE=Ovarian carcinoma;
PubMed=11162530; DOI=10.1006/bbrc.2000.4126;
Luo L.Y., Soosaipillai A., Diamandis E.P.;
"Molecular cloning of a novel human gene on chromosome 4p11 by
immunoscreening of an ovarian carcinoma cDNA library.";
Biochem. Biophys. Res. Commun. 280:401-406(2001).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Pituitary tumor;
Xu X., Yang Y., Gao G., Xiao H., Chen Z., Han Z.;
Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
TISSUE=Fetal brain;
Li W.B., Gruber C., Jessee J., Polayes D.;
"Full-length cDNA libraries and normalization.";
Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=15815621; DOI=10.1038/nature03466;
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2
and 4.";
Nature 434:724-731(2005).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108 AND SER-191, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in
signaling networks.";
Cell 127:635-648(2006).
[9]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
Greff Z., Keri G., Stemmann O., Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of
the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
[10]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[11]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Leukemic T-cell;
PubMed=19690332; DOI=10.1126/scisignal.2000007;
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
Rodionov V., Han D.K.;
"Quantitative phosphoproteomic analysis of T cell receptor signaling
reveals system-wide modulation of protein-protein interactions.";
Sci. Signal. 2:RA46-RA46(2009).
[12]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19608861; DOI=10.1126/science.1175371;
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
Walther T.C., Olsen J.V., Mann M.;
"Lysine acetylation targets protein complexes and co-regulates major
cellular functions.";
Science 325:834-840(2009).
[13]
FUNCTION.
PubMed=20515946; DOI=10.1158/1535-7163.MCT-09-1024;
Wang C., Michener C.M., Belinson J.L., Vaziri S., Ganapathi R.,
Sengupta S.;
"Role of the 18:1 lysophosphatidic acid-ovarian cancer immunoreactive
antigen domain containing 1 (OCIAD1)-integrin axis in generating late-
stage ovarian cancer.";
Mol. Cancer Ther. 9:1709-1718(2010).
[14]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=20068231; DOI=10.1126/scisignal.2000475;
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
Mann M.;
"Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis.";
Sci. Signal. 3:RA3-RA3(2010).
[15]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[16]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-123 AND
SER-191, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
PubMed=21406692; DOI=10.1126/scisignal.2001570;
Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
Blagoev B.;
"System-wide temporal characterization of the proteome and
phosphoproteome of human embryonic stem cell differentiation.";
Sci. Signal. 4:RS3-RS3(2011).
[17]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-116 AND
SER-123, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[18]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-123 AND SER-191, AND
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Liver;
PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
Wang L., Ye M., Zou H.;
"An enzyme assisted RP-RPLC approach for in-depth analysis of human
liver phosphoproteome.";
J. Proteomics 96:253-262(2014).
[19]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=25944712; DOI=10.1002/pmic.201400617;
Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
"N-terminome analysis of the human mitochondrial proteome.";
Proteomics 15:2519-2524(2015).
-!- FUNCTION: Maintains stem cell potency (By similarity). Increases
STAT3 phosphorylation and controls ERK phosphorylation (By
similarity). May act as a scaffold, increasing STAT3 recruitment
onto endosomes (By similarity). Involved in integrin-mediated
cancer cell adhesion and colony formation in ovarian cancer
(PubMed:20515946). {ECO:0000250|UniProtKB:Q9CRD0,
ECO:0000269|PubMed:20515946}.
-!- SUBUNIT: Interacts with STAT3. {ECO:0000250|UniProtKB:Q9CRD0}.
-!- INTERACTION:
P17544:ATF7; NbExp=2; IntAct=EBI-2683029, EBI-765623;
-!- SUBCELLULAR LOCATION: Endosome {ECO:0000250|UniProtKB:Q9CRD0}.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=4;
Name=1; Synonyms=A;
IsoId=Q9NX40-1; Sequence=Displayed;
Name=2; Synonyms=B;
IsoId=Q9NX40-2; Sequence=VSP_027621, VSP_027622;
Name=3;
IsoId=Q9NX40-3; Sequence=VSP_027622;
Name=4;
IsoId=Q9NX40-4; Sequence=VSP_046212;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Isoform 1 is highly expressed in many tissues,
including testis, brain, placenta, ovary, prostate and mammary
gland. Isoform 2 expression is restricted to the central nervous
system including brain, cerebellum and spinal cord.
{ECO:0000269|PubMed:11162530}.
-!- DOMAIN: The OCIA domain is necessary and sufficient for endosomal
localization. {ECO:0000250|UniProtKB:Q9CRD0}.
-!- MISCELLANEOUS: 'Asrij' stands for 'blood' in Sanskrit as this
protein is strongly expressed in blood vessels.
-!- SIMILARITY: Belongs to the OCIAD1 family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AF323665; AAG45220.1; -; mRNA.
EMBL; AF324350; AAK12121.1; -; mRNA.
EMBL; AF251296; AAG44596.1; -; mRNA.
EMBL; AL539411; -; NOT_ANNOTATED_CDS; mRNA.
EMBL; AK000462; BAA91181.1; -; mRNA.
EMBL; AC079927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; CH471069; EAW93070.1; -; Genomic_DNA.
EMBL; BC003409; AAH03409.1; -; mRNA.
EMBL; BC088361; AAH88361.1; -; mRNA.
CCDS; CCDS3484.1; -. [Q9NX40-1]
CCDS; CCDS43228.1; -. [Q9NX40-2]
CCDS; CCDS47052.1; -. [Q9NX40-4]
PIR; JC7586; JC7586.
RefSeq; NP_001073308.1; NM_001079839.2. [Q9NX40-1]
RefSeq; NP_001073309.1; NM_001079840.2. [Q9NX40-4]
RefSeq; NP_001073310.1; NM_001079841.2. [Q9NX40-2]
RefSeq; NP_001073311.2; NM_001079842.2. [Q9NX40-4]
RefSeq; NP_060300.1; NM_017830.3. [Q9NX40-1]
RefSeq; XP_016863818.1; XM_017008329.1. [Q9NX40-2]
UniGene; Hs.518750; -.
ProteinModelPortal; Q9NX40; -.
BioGrid; 120280; 83.
IntAct; Q9NX40; 53.
MINT; Q9NX40; -.
STRING; 9606.ENSP00000264312; -.
iPTMnet; Q9NX40; -.
PhosphoSitePlus; Q9NX40; -.
SwissPalm; Q9NX40; -.
BioMuta; OCIAD1; -.
DMDM; 74734685; -.
EPD; Q9NX40; -.
MaxQB; Q9NX40; -.
PaxDb; Q9NX40; -.
PeptideAtlas; Q9NX40; -.
PRIDE; Q9NX40; -.
ProteomicsDB; 83031; -.
ProteomicsDB; 83032; -. [Q9NX40-2]
ProteomicsDB; 83033; -. [Q9NX40-3]
TopDownProteomics; Q9NX40-1; -. [Q9NX40-1]
TopDownProteomics; Q9NX40-2; -. [Q9NX40-2]
TopDownProteomics; Q9NX40-3; -. [Q9NX40-3]
DNASU; 54940; -.
Ensembl; ENST00000264312; ENSP00000264312; ENSG00000109180. [Q9NX40-1]
Ensembl; ENST00000381473; ENSP00000370882; ENSG00000109180. [Q9NX40-1]
Ensembl; ENST00000396448; ENSP00000379725; ENSG00000109180. [Q9NX40-2]
Ensembl; ENST00000425583; ENSP00000416943; ENSG00000109180. [Q9NX40-4]
Ensembl; ENST00000444354; ENSP00000399656; ENSG00000109180. [Q9NX40-4]
Ensembl; ENST00000508293; ENSP00000423002; ENSG00000109180. [Q9NX40-1]
Ensembl; ENST00000513391; ENSP00000423909; ENSG00000109180. [Q9NX40-1]
GeneID; 54940; -.
KEGG; hsa:54940; -.
UCSC; uc003gyo.4; human. [Q9NX40-1]
CTD; 54940; -.
DisGeNET; 54940; -.
EuPathDB; HostDB:ENSG00000109180.14; -.
GeneCards; OCIAD1; -.
HGNC; HGNC:16074; OCIAD1.
HPA; HPA044803; -.
neXtProt; NX_Q9NX40; -.
OpenTargets; ENSG00000109180; -.
PharmGKB; PA134898158; -.
eggNOG; ENOG410IZC9; Eukaryota.
eggNOG; ENOG4111R9S; LUCA.
GeneTree; ENSGT00530000063690; -.
HOGENOM; HOG000047933; -.
HOVERGEN; HBG108207; -.
InParanoid; Q9NX40; -.
OMA; YEVTLTH; -.
OrthoDB; EOG091G0USR; -.
PhylomeDB; Q9NX40; -.
TreeFam; TF327106; -.
ChiTaRS; OCIAD1; human.
GenomeRNAi; 54940; -.
PRO; PR:Q9NX40; -.
Proteomes; UP000005640; Chromosome 4.
Bgee; ENSG00000109180; Expressed in 212 organ(s), highest expression level in caudate nucleus.
CleanEx; HS_OCIAD1; -.
ExpressionAtlas; Q9NX40; baseline and differential.
Genevisible; Q9NX40; HS.
GO; GO:0005768; C:endosome; ISS:UniProtKB.
GO; GO:0016020; C:membrane; HDA:UniProtKB.
GO; GO:2000736; P:regulation of stem cell differentiation; ISS:UniProtKB.
InterPro; IPR009764; OCIA.
Pfam; PF07051; OCIA; 1.
1: Evidence at protein level;
Alternative splicing; Complete proteome; Endosome; Phosphoprotein;
Reference proteome.
CHAIN 1 245 OCIA domain-containing protein 1.
/FTId=PRO_0000299382.
DOMAIN 1 112 OCIA.
MOD_RES 108 108 Phosphoserine.
{ECO:0000244|PubMed:17081983,
ECO:0000244|PubMed:18691976,
ECO:0000244|PubMed:19690332,
ECO:0000244|PubMed:20068231,
ECO:0000244|PubMed:21406692,
ECO:0000244|PubMed:23186163}.
MOD_RES 116 116 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 123 123 Phosphoserine.
{ECO:0000244|PubMed:21406692,
ECO:0000244|PubMed:23186163,
ECO:0000244|PubMed:24275569}.
MOD_RES 191 191 Phosphoserine.
{ECO:0000244|PubMed:17081983,
ECO:0000244|PubMed:21406692,
ECO:0000244|PubMed:24275569}.
VAR_SEQ 183 233 Missing (in isoform 4).
{ECO:0000303|Ref.3}.
/FTId=VSP_046212.
VAR_SEQ 184 187 PDPN -> RNFS (in isoform 2).
{ECO:0000303|PubMed:11162530}.
/FTId=VSP_027621.
VAR_SEQ 188 245 Missing (in isoform 2 and isoform 3).
{ECO:0000303|PubMed:11162530}.
/FTId=VSP_027622.
SEQUENCE 245 AA; 27626 MW; B4CD4F4B5483884D CRC64;
MNGRADFREP NAEVPRPIPH IGPDYIPTEE ERRVFAECND ESFWFRSVPL AATSMLITQG
LISKGILSSH PKYGSIPKLI LACIMGYFAG KLSYVKTCQE KFKKLENSPL GEALRSGQAR
RSSPPGHYYQ KSKYDSSVSG QSSFVTSPAA DNIEMLPHYE PIPFSSSMNE SAPTGITDHI
VQGPDPNLEE SPKRKNITYE ELRNKNRESY EVSLTQKTDP SVRPMHERVP KKEVKVNKYG
DTWDE


Related products :

Catalog number Product name Quantity
EIAAB28606 Homo sapiens,Human,OCIA,OCIA domain-containing protein 1,OCIAD1,Ovarian carcinoma immunoreactive antigen
EIAAB28610 Homo sapiens,Human,OCIA domain-containing protein 2,OCIAD2,Ovarian carcinoma immunoreactive antigen-like protein
5465 Ovarian cancer immuno-reactive antigen domain-containing protein 2 0.5 mg
5461 Ovarian cancer immuno-reactive antigen domain-containing protein 1 0.1 mg
5461 Ovarian cancer immuno-reactive antigen domain-containing protein 1 0.5 mg
5465 Ovarian cancer immuno-reactive antigen domain-containing protein 2 0.1 mg
5463 Ovarian cancer immuno-reactive antigen domain-containing protein 2 0.1 mg
5463 Ovarian cancer immuno-reactive antigen domain-containing protein 2 0.5 mg
E0154h ELISA CA125,CA-125,Homo sapiens,Human,MUC16,MUC-16,Mucin-16,Ovarian cancer-related tumor marker CA125,Ovarian carcinoma antigen CA125 96T
E0154h ELISA kit CA125,CA-125,Homo sapiens,Human,MUC16,MUC-16,Mucin-16,Ovarian cancer-related tumor marker CA125,Ovarian carcinoma antigen CA125 96T
U0154h CLIA CA125,CA-125,Homo sapiens,Human,MUC16,MUC-16,Mucin-16,Ovarian cancer-related tumor marker CA125,Ovarian carcinoma antigen CA125 96T
SER870Hu ELISA Kit for Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2 (OCIAD2) Homo sapiens (Human) 96T
E04O0338 Rabbit Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125 96 Tests/kit
E11O0338 Bovine Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125 96 Tests/kit
E08O0338 Canine Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125
E11O0338 Bovine Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125
E09O0338 Monkey Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125 96 Tests/kit
E12O0338 Chicken Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125 96 Tests/kit
E05O0338 Guinea pig Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125
E06O0338 Goat Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125
E12O0338 Chicken Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125
E07O0338 Porcine Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125 96 Tests/kit
E03O0338 Mouse Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125
E06O0338 Goat Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125 96 Tests/kit
E14O0338 Sheep Ovarian cancer marker_Carbohydrate antigen 125 ELISA, Ovarian cancer marker-CA125 96 Tests/kit


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur